Capital Research Global Investors - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 147 filers reported holding CONMED CORP in Q4 2016. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital Research Global Investors ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$248,808,245
-25.9%
2,467,112
-0.2%
0.07%
-23.3%
Q2 2023$335,926,467
+34.7%
2,472,047
+2.9%
0.09%
+26.8%
Q1 2023$249,445,755
+28.4%
2,401,750
+9.5%
0.07%
+20.3%
Q4 2022$194,333,804
+39.4%
2,192,394
+26.0%
0.06%
+28.3%
Q3 2022$139,449,000
-4.9%
1,739,412
+13.6%
0.05%0.0%
Q2 2022$146,569,000
-13.4%
1,530,589
+34.3%
0.05%
+9.5%
Q1 2022$169,251,000
+5.9%
1,139,356
+1.1%
0.04%
+20.0%
Q4 2021$159,771,000
+19.3%
1,127,056
+10.1%
0.04%
+12.9%
Q3 2021$133,969,000
+3.0%
1,023,995
+8.2%
0.03%
+3.3%
Q2 2021$130,008,000
+19.6%
945,995
+13.7%
0.03%
+11.1%
Q1 2021$108,663,000
+35.1%
832,095
+15.8%
0.03%
+28.6%
Q4 2020$80,450,000
+47.2%
718,300
+3.4%
0.02%
+31.2%
Q3 2020$54,636,000
+29.8%
694,500
+18.8%
0.02%
+23.1%
Q2 2020$42,078,000
-49.3%
584,500
-59.7%
0.01%
-60.6%
Q1 2020$83,070,000
-65.6%
1,450,500
-32.7%
0.03%
-54.2%
Q4 2019$241,178,000
+10.5%
2,156,651
-5.0%
0.07%0.0%
Q3 2019$218,276,000
+12.4%
2,270,1620.0%0.07%
+16.1%
Q2 2019$194,258,000
+22.8%
2,270,162
+19.4%
0.06%
+24.0%
Q1 2019$158,139,000
+61.9%
1,901,162
+24.9%
0.05%
+47.1%
Q4 2018$97,691,000
-28.3%
1,521,662
-11.5%
0.03%
-15.0%
Q3 2018$136,179,000
+16.0%
1,719,000
+7.2%
0.04%
+25.0%
Q2 2018$117,384,000
+39.6%
1,603,606
+20.8%
0.03%
+33.3%
Q1 2018$84,077,000
+65.8%
1,327,600
+33.4%
0.02%
+60.0%
Q4 2017$50,716,000
+9.7%
995,014
+12.9%
0.02%
+7.1%
Q3 2017$46,226,000
+3.0%
881,0000.0%0.01%0.0%
Q2 2017$44,878,000
-6.7%
881,000
-18.7%
0.01%
-6.7%
Q1 2017$48,096,000
-12.9%
1,083,000
-13.4%
0.02%
-16.7%
Q4 2016$55,244,000
+10.3%
1,250,7190.0%0.02%
+5.9%
Q3 2016$50,104,000
-16.1%
1,250,7190.0%0.02%
-15.0%
Q2 2016$59,697,000
+13.8%
1,250,7190.0%0.02%
+11.1%
Q1 2016$52,455,000
-11.3%
1,250,719
-6.8%
0.02%
-10.0%
Q4 2015$59,145,000
-7.7%
1,342,6890.0%0.02%
-13.0%
Q3 2015$64,100,000
-7.8%
1,342,689
+12.6%
0.02%0.0%
Q2 2015$69,496,000
+71.4%
1,192,648
+48.5%
0.02%
+64.3%
Q1 2015$40,543,000
+12.3%
803,0000.0%0.01%
+16.7%
Q4 2014$36,103,000
+22.0%
803,0000.0%0.01%
+20.0%
Q3 2014$29,583,000
+66.3%
803,000
+99.3%
0.01%
+66.7%
Q2 2014$17,792,000
-13.8%
403,000
-15.2%
0.01%
-14.3%
Q1 2014$20,639,000
+2.2%
475,0000.0%0.01%0.0%
Q4 2013$20,188,000
+25.0%
475,0000.0%0.01%
+16.7%
Q3 2013$16,145,000
+8.8%
475,0000.0%0.01%0.0%
Q2 2013$14,839,000475,0000.01%
Other shareholders
CONMED CORP shareholders Q4 2016
NameSharesValueWeighting ↓
Endurant Capital Management LP 41,984$4,234,0863.80%
Ranger Investment Management 334,874$33,772,0432.24%
SECTORAL ASSET MANAGEMENT INC 114,000$11,496,9002.24%
EARNEST PARTNERS LLC 2,265,092$228,434,5281.32%
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID 144,376$14,560,3201.01%
EPIQ PARTNERS, LLC 10,463$1,055,1940.80%
Hood River Capital Management LLC 236,127$23,813,4080.76%
Heritage Wealth Partners, LLC 3,375$340,3690.73%
Champlain Investment Partners, LLC 943,260$95,127,7710.62%
WESTWOOD HOLDINGS GROUP INC 559,157$56,3910.53%
View complete list of CONMED CORP shareholders